– with panelists Avtar Dhillon, M.D., Joseph Kim, Ph.D., Michael Egan, Ph.D., Jeffrey Ulmer, Ph.D., Alan King, Ph.D., and Robert Bernard

Previous articleOpsona Closes $23M Financing Round
Next articleEisai Licenses Bial’s Antiepileptic Drug for European Market for $120M